Levobunolol
RxNorm 1813
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1813 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Levobunolol.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Levobunolol
(Atom ID: 12252685)
PTPrescribable
Designated preferred name (PT):
Levobunolol
(Atom ID: 2384574)
FNPrescribable
Full form of descriptor (FN):
Levobunolol (substance)
(Atom ID: 2384575)
PTPrescribable
Designated preferred name (PT):
Levobunolol-containing product
(Atom ID: 10805941)
FNPrescribable
Full form of descriptor (FN):
Product containing levobunolol (medicinal product)
(Atom ID: 9724758)
Patient Education
Levobunolol Ophthalmic
Ophthalmic levobunolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Levobunolol is in a class of medications called beta blockers. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.